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BALB/c mice immunized with a vaccinia virus recombinant expressing the influenza A virus (A/Udorn/72; subtype H3)
hemagglutinin HA2 (H3HA2) induced a strong CD8/ cytotoxic T lymphocyte (CTL) response which was H-2d-restricted. Two
peptides, derived from the primary sequence of the H3HA2 and consistent with the predictive motif for Kd-restricted
epitopes, were tested for their ability to be presented to the CTLs by P815 cells. Peptides corresponding to the amino acids
93SYNAELLVAL102 and 181GYKDWILWI189 of the HA2 primary sequence sensitized target cells for lysis by the HA2-specific
CTLs. Secondary in vitro stimulation with dendritic cells as a source of antigen presenting cells treated with peptide 93-
102, or infected with recombinant vaccinia virus (HA2-VACC), induced type A cross-reactive CTLs from A/Udorn/72 immune
spleen cells. This CD8/ CTL epitope overlaps with an H3HA2 I-Ad-restricted T helper epitope 96-104 recently reported by
others. The H3HA2 epitope described here is the first CTL epitope in the influenza hemagglutinin which is found in all three
subtypes of influenza A virus. q 1995 Academic Press, Inc.
INTRODUCTION 1977a,b), which recognize cells infected with two or three
of the subtypes of influenza A virus, i.e., H1, H2, or H3.
The ability of T cells to recognize foreign antigens as Most type A cross-reactive CTL are specific for internal
either degraded or processed peptides in the context of antigens, whereas subtype-specific CTL may recognize
self major histocompatibility complex (MHC) molecules either internal or external proteins. To date, determinants
(Bjorkman, 1990; Davis and Bjorkman, 1988) is central to cross-reactive for H1 and H2 subtypes have been located
the antiviral immune response. For the most part, cyto- within amino acid residues 189–199 of the transmem-
toxic T lymphocytes (CTLs) recognize antigen presented brane domain of the HA2 molecule (Kuwano et al., 1989;
by class I MHC molecules, whereas T helper cells recog- Braciale et al., 1989) and within amino acid residues
nize antigens presented by class II MHC molecules (re- 103–123 of A/JAP/57 (subtype H2) HA2 (Wabuke-Bunoti
viewed by Germain and Margulies, 1993). and Fan, 1983). CTLs specific for the H3 hemagglutinin
Infection by influenza A virus is followed by a vigorous have been described as subtype specific (Itamura et al.,
CTL response in both mouse (Lin and Askonas, 1981; 1990). Therefore, no fully type A cross-reactive CTL epi-
Lukacher et al., 1984; Bennink et al., 1984, 1987; Gould topes in the influenza hemagglutinin have yet been de-
et al., 1987; Kuwano et al., 1990; Reay et al., 1989; Town- scribed.
send, 1987) and man (Brett et al., 1991; Gotch et al., 1987, Recently, elution recovery and amino acid sequencing
1988). These CTLs were found to be specific for surface of peptides from five MHC class I molecules have al-
glycoproteins (Bennink et al., 1984, 1986; Gould et al., lowed the determination of allele-specific peptide bind-
1991; Torres et al., 1988; Townsend, 1987; Wysocka and ing motifs (Falk et al., 1991a,b; Jardetzky et al., 1991;
Hackett, 1990; Wysocka et al., 1994), internal proteins Rotzchke and Falk, 1991; Rotzchke et al., 1990, 1991)
(Yewdell et al., 1985; Bennink et al., 1987; Brett et al., which facilitated identification of class I-restricted epi-
1991; Reay et al., 1989; Townsend et al., 1986), and non- topes in parasites, bacteria, and viruses (Bonneau et al.,
structural proteins (Bennink et al., 1987; Cossins et al., 1993; DiBrino et al., 1993; Kulkarni et al., 1993; Kutubud-
1993; Kuwano et al., 1990; Saikh et al., 1993). There are din et al., 1992; Pamer et al., 1991). Because CTL epi-
two type A influenza-specific CTLs: the subtype specific topes in the H3 HA have not been well studied, our goal
(Braciale et al., 1981; Effors et al., 1977), which preferen- was to determine the H3HA2-specific CTL response and
tially recognize subtypes used for immunization, and the to define the class I-restricted CTL epitope(s) within that
cross-reactive (Kuwano et al., 1988; Zweernik et al., HA2 domain. During this course we uncovered a con-
served H-2Kd-restricted epitope which is recognized by
influenza type A cross-reactive CTL. This is the first CTL1 To whom reprint requests should be addressed at: Department of
recognized epitope in the influenza hemagglutinin whichImmunology and Molecular Biology, R. I. I. D./Bld. 1425, Frederick, MD
21702. Fax: (301) 619-2348. is found in all three subtypes of influenza A virus.
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MATERIALS AND METHODS al., 1993). WR-infected 143BTK0 cells and (mock-infected)
143BTK0 cells were used as negative controls, and A/
Viruses Udorn/72-infected 143BTK0 cells were used as a positive
control. After four successive plaque purifications, theVaccinia virus strain WR obtained from Dr. Elaine
recombinant vaccinia virus containing the H3HA2 geneJones (SmithKline Beecham) was grown in CV-1 cells.
was amplified by infecting 143BTK0 cell monolayers inInfluenza A virus strains A/PR/8/34 (A/Puerto Rico/8/34,
presence of BrdUr and was then grown in CV-1 cellsH1N1), A/JAP/57 (A/Japan/305/57, H2N2), and A/Udorn/
without selection.72 (H3N2) were propagated in 10-day-old embryonated
chicken eggs. Allantoic fluids were harvested 2 days after
infection, aliquoted, and stored at 0807. Mice and immunization
Cell lines BALB/c (H-2d) mice were purchased from Charles
River Breeding Laboratories (Raleigh, NC). Mice (6 to 8
143BTK0 cells (osteosarcoma) obtained from the weeks of age) were immunized intraperitoneally with A/
American Type Culture Collection (ATCC) were grown in Udorn/72 or A/PR/8/34 (5 1 107 PFU/0.2 ml) or with re-
Eagle’s medium with 10% fetal bovine serum and 25 mg combinant vaccinia virus (H3HA2-VACC) (5 1 107 PFU/
of 5-bromodeoxyuridine (BrdUr) per milliliter. CV-1 cells 0.2 ml). Spleen cells were obtained 3 to 4 weeks later
were grown in Dulbecco’s modified medium containing for generating effector cells.
10% fetal bovine serum. P815 (H-2d), EL-4 (H-2b), and
BW5147 (H-2k) cells were used as target cells for cytotox-
Isolation of dendritic cellsicity assays. The P815 and BW5147 cell lines were grown
in Dulbecco’s modified Eagle’s medium and EL-4 cells Lymphoid dendritic cells (DCs) were enriched from
were grown in RPMI supplemented with 10% fetal bovine nonadherent spleen cells after overnight culture using
serum (FCS). Hybridoma cell lines, which produced sequential adherence to petri dishes. Briefly, spleen cells
monoclonal antibodies specific for mouse CD8 (53-6.72; at 5–10 1 106/ml were plated in (100 1 15 cm) tissue
ATCC TIB105), and mouse CD4 (GK1.5; ATCC TIB207), culture dishes and incubated at 377 in complete RPMI
were grown in RPMI 1640 plus 10% fetal bovine serum medium containing 10% FCS. Ninety minutes later, cells
or Dulbecco’s modified Eagle’s medium supplemented were washed with warm RPMI twice and incubated with
with 20% fetal bovine serum, respectively. 12 ml medium overnight at 377. After overnight culture,
the nonadherent cells were collected by aspirating theConstruction of recombinant vaccinia virus
medium and then plated onto new tissue culture dishesexpressing the influenza H3HA2 gene
in order to readhere the contaminating macrophages.
After 1 hr, DCs were collected by aspirating mediumThe entire H3 subtype hemagglutinin HA2 gene (663
bp) was generated by PCR amplification from the pUC18 followed by centrifugation. The purity of dendritic cells
ranged from 50 to 70% based on staining with the DC-plasmid containing the entire cDNA of the hemagglutinin
of A/Udorn/72 (obtained from Miller Scott, SmithKline specific MAb 33D1 (Nussenzweig et al., 1982).
Beecham), using 5* primers containing a SmaI linker with
an ATG codon followed by the HA2 sequence and a 3* Generation of murine polyclonal CTL cultures in vitro
primer containing a SmaI linker followed by the 3* end
sequence of the HA2. The PCR product was digested Three weeks after priming of mice, the spleens were
removed and the spleen cells were stimulated in vitro.with restriction endonuclease SmaI enzyme and used for
ligation to the SmaI-digested and alkaline phosphatase- Briefly, 5 1 106 spleen cells were cultured with 5 1 105
to 1 1 106 stimulator dendritic cells and infected withtreated pSC11 vaccinia virus expression vector. The cor-
rectly oriented plasmid constructs were selected based either influenza virus (A/Udorn/72) or recombinant vac-
cinia virus (H3HA2-VACC), at a multiplicity of infection ofon independent restriction mapping by XhoI and SmaI
digestion. DNA sequencing of the entire H3HA2 gene in 10 to 20 PFU per cell in 2 ml of complete medium (RPMI
1640 supplemented with 10% fetal calf serum, 2mM gluta-the pSC11 plasmid confirmed the sequence to be identi-
cal to the A/Udorn/72 HA2 sequence (Jou et al., 1980; mine, 10 mM HEPES, 5 1 1005 M 2-mercaptoethanol, 100
IU/ml penicillin, and 100 mg/ml streptomycin) in 24-wellYuferov et al., 1984).
The H3HA2 gene in pSC11 was then transfected into plates. For stimulation by synthetic peptides, dendritic
cells were incubated with peptide for 1 hr at 377 prior toCV-1 cells infected with wild-type vaccinia virus (WR) to
allow homologous recombination as described pre- addition to cultures and were then cultured with immune
spleen cells in 24-well plates at a final peptide concentra-viously (Chakrabarti et al., 1985; Saikh et al., 1993). Posi-
tive recombinants were purified by sequential plaque pu- tion of 25 mM and 10% rat Concanavalin A (ConA) super-
natant containing medium (ConA sup) (Shirai et al., 1992,rification in the 143BTK0 cell line in presence of 5-bromo-
deoxyuridine (BrdUr), followed by RNA:DNA dot blot 1994). Cultures were harvested after 5 days of incubation
at 377 for testing in a 51Cr-release assay.hybridization using the H3HA2 gene as a probe (Saikh et
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Cytotoxicity assay cells pulsed with H3HA2 93-102 over a wide dose range,
with the peak response being seen at 0.1 mM peptide
P815, EL-4, and BW5147 target cells were infected with for both of the E:T ratios studied (Fig. 1A). These poly-
influenza virus (40 to 60 PFU per cell) 8 hr prior to assay clonal CTLs also recognized P815 targets when sensi-
or with recombinant vaccinia virus (H3HA2-VACC) at a tized with an another H3HA2 peptide 181-189 matching
multiplicity of 20 to 40 PFU per cell for 12 to 16 hr prior at the anchor residues (Fig. 1B).
to the assay. Infected target cells were incubated with To determine whether virus-infected targets were also
300 mCi of 51Na2CrO4 for 90 min prior to assay. For pep- recognized, P815 cells infected with H1, H2, or H3 influ-
tide-pulsed targets, 50 ml peptide suspended in RPMI enza virus were examined. Results shown in Table 2
1640 was directly added to wells containing 51Cr-labeled demonstrate that secondary in vitro stimulation with pep-
target cells. Target cells were incubated with effector tide H3HA2 93-102 induced cross-reactive CTLs which
cells (100 ml) at the indicated E:T ratios in a 96-well recognized targets infected with A/PR/8/34, A/JAP/305/
round-bottom microtiter plate for 4 hr. Supernatant fluids 57, and A/Udorn/72 viruses.
(100 ml) were taken and 51Cr was measured in a gamma
counter. Percentage specific lysis was determined as Vaccinia virus recombinant (H3HA2-VACC) primes
follows: Percentage specific lysis  100 (experimental BALB/c mice for a secondary influenza A virus-
release 0 minimum release)/(maximum release 0 mini- specific CD8/ CTL response
mum release), where spontaneous release was deter-
Splenocytes from mice immunized with recombinantmined by incubating target cells in medium, and maxi-
vaccinia virus containing the H3HA2 gene were stimu-mum release by incubating in 1% sodium dodecyl sul-
lated with DC pulsed with the H3HA2 peptide 93-102.phate. Assays were performed in triplicate wells.
Recognition of targets either infected with influenza ASpontaneous release of 51Cr from target cells varied be-
virus or sensitized with the H3HA2-derived peptide wastween 10 and 20%.
significant at 50:1 and 100:1 E:T ratios (Fig. 2). In addition,
these polyclonal CTLs lysed target cells sensitized withSynthetic peptides
recombinant vaccinia virus containing H3HA2 (H3HA2-
Peptides were prepared on a Biosearch peptide syn- VACC) but did not lyse targets infected with wild-type
thesizer (Model 9600) by F-moc chemistry. Peptides were vaccinia virus (WR-VACC) (Fig. 2) indicating the specific-
purified to 95% purity by reverse-phase analytical high- ity of recognition. Splenocytes derived from WR-VACC-
performance liquid chromatography and structures were primed mice and stimulated in vitro with the H3HA2 93-
confirmed by mass spectrometry. 102 did not lyse target cells sensitized with the H3HA2-
derived peptide (data not shown). Thus, a vaccinia virus
Antibody blocking of cytotoxicity recombinant expressing the HA2 of A/Udorn/72 was able
to stimulate immune responses in BALB/c mice and alsoAnti-CD8 and anti-CD4 MAb at a final concentration
sensitized target cells for lysis by appropriately gener-10 mg/ml (50 ml) were added to 50 ml of 51Cr-labeled
ated CTL populations.target cells pulsed with peptide (104 cells per well) in 96-
To determine the phenotype of the bulk population ofwell round-bottom plates for 30 min; this was followed
H3HA2-specific CTL, we performed blocking experi-by addition of 100 ml of effector cells for incubation at
ments with anti-CD8 and anti-CD4 monoclonal antibod-377 for 4 hr.
ies. Anti-CD8 (53-6.72) antibody reduced the cytolytic ac-
tivity of these effector cells to background levels,RESULTS
whereas anti CD4 (GK1.5) had no significant effect on
Recognition of H3HA2-derived peptides by influenza CTL activity (Fig. 2), demonstrating that the H-2d poly-
virus-specific CTLs in bulk culture clonal CTLs were CD8/.
The hemagglutinin HA2 subunit of influenza virus A H-2Kd allele specificity of the CTLs that recognize the
(A/Udorn/72) consists of 222 amino acid residues and H3HA2-derived peptides
contains two Kd consensus motifs (Falk et al., 1991b)
which have a tyrosine residue at position 2 and either Influenza virus immune splenocytes from BALB/c mice
stimulated with the H3HA2-derived peptide (93-102) asAla, Leu at position 9, 10 (93-102) or Ile at position 9
(181-189) (Table 1). These peptides were synthesized described above lysed P815 (H-2b) target cells sensitized
with H3HA2 peptides 93-102 and 181-189, but did notand used to sensitize P815 cells for lysis by lymphocytes
derived from spleens of A/Udorn/72-infected mice which lyse EL-4 (H-2b) target cells sensitized with a peptide
(NP364-379) representing a known Db restricted epitopewere stimulated in vitro with dendritic cells pulsed with
peptide H3HA2 93-102. H3HA2 peptide 93-102 was used in the nucleoprotein (NP) of A/PR/8/34 (Townsend et al.,
1986) (Fig. 3). NP 364-379 peptide-pulsed and A/PR/8/for in vitro stimulation in bulk culture because of high
sequence homology in this region with the H1 and H2 34-infected EL-4 targets were efficiently lysed by virus
immune spleen cells from C57BL/6 (H-2b) mice as ex-virus (Table 1). CTL from these cultures recognized target
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TABLE 1
Comparable Sequence Similarity and Location of CTL and T Helper Epitopes in the Hemagglutinin HA2 Subunit
among Subtypes of Influenza A Virus
HA2
Subtype Virus sequence Locationa T cell responseb Reference
H3 A/Udorn/72 SYNAELLVAL (93–102)c CTL Present study
H2 A/JAP/57 TYNAELLVLM (93–102) CTL Present study
H1 A/PR/8/34 TYNAELLVLL (93–102) CTL Present study
H3 A/Memphis/102/72 AELLVALEN (96–104) T helper Jackson et al. (1994)
H3 A/Memphis/102/72 RFQIKGVEL (170–178) T helper Jackson et al. (1994)
H3 A/Udorn/72 GYKDWILWI (181–189)c CTL Present study
H2 A/JAP/57 MGVYQILAI (181–189)d Not known
H1 A/PR/8/34 MGIYQILAI (181–189)d Not known
H3 A/Udorn/72 ISFAISCFLLC (189–199)d Not known
H2 A/JAP/57 IYATVAGSLSL (189–199) CTL Kuwano et al. (1989)
H1 A/PR/8/34 IYSTVASSLVL (189–199) CTL Kuwano et al. (1989)
a Amino acids are numbered according to their sequence in the HA2 subunit based on the proteolytic cleavage site at the arginine residue (Ward,
1981).
b Cytotoxic T lymphocyte (CTL) response determined by 51Cr-release assay (described under Materials and Methods) in this study or T helper
and T cytotoxic response as reported by others (Jackson et al., 1994; Kuwano et al., 1989).
c Two peptides that conform to the H-2Kd binding motif (Falk et al., 1991b) were found in the hemagglutinin HA2 subunit of influenza A virus H3
subtype. Peptides were aligned according to their anchor domain residue, e.g., second-position tyrosine and ninth- or tenth-position hydrophobic
residues isoleucine, leucine, or valine.
d Sequence does not fit with H-2Kd consensus motif.
pected (data not shown). Immune splenocytes stimulated ated from spleen cells of BALB/c mice primed with
H3HA2-VACC and stimulated in vitro with either dendriticwith peptide H3HA2 93-102 also did not show specific
lysis of P815 cells sensitized with a control Kd-restricted cells infected with H3HA2-VACC or treated with peptide
H3HA2 93-102 lysed only P815 (H-2d), but not BW5147 (H-epitope (NP147-158)(Bodmer et al., 1988). CTLs gener-
FIG. 1. Recognition of H-2d target cells sensitized with H3HA2-derived peptides by influenza virus-specific CTLs in bulk culture. Effectors were
splenocytes from BALB/c mice immunized intraperitoneally with A/Udorn/72 (5 1 107 PFU/0.2 ml) 3 to 4 weeks previously and stimulated in vitro
with peptide 93-102 plus 10% rat ConA sup as described under Materials and Methods. Panels A and B represent target sensitization with peptides
93-102 and 181-189, respectively.
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TABLE 2 (1990) demonstrated that an H3HA–vaccinia recombi-
nant expressing the entire H3HA could prime BALB/cRecognition of H1, H2, and H3 Subtype Influenza Virus-Infected
mice for an H3 subtype-specific CTL response; but, itTargets by Virus Immune Spleen Cells Restimulated in Vitro with
H3HA2 Peptide 93–102 was not clear whether these CTLs were directed to the
HA1 or HA2 subunit. Subtype H3 HA-specific CTLs were
Percentage specific lysis by effector cells stimu- also demonstrated in C3H mice (Torres et al., 1988) and
lated with HA2-derived peptidea
mapped to a determinant in the HA2 at amino acid resi-Virus used
dues 56–68 and 68–84 using synthetic peptides (recog-to sensitize Experiment 1 Experiment 2
P815 target nition of H1 and H2 subtypes was not studied). Of the
cells 100:1b 50:1 100:1 50:1 two H3HA2-derived peptides Torres et al. (1988) studied,
we found (by sequence alignment analysis) peptide 68-
Untreated 25.9 16.6 28.3 21.0
84 to contain an H-2Kk-restricted class I consensus motifA/PR/8/34 50.1 35.8 45.6 34.6
matching with a published Kk epitope in the nonstructuralA/JAP/57 55.7 47.4 ND ND
A/Udorn/72 56.4 46.7 51.0 47.0 (NS1) protein of influenza A virus (Cossins et al., 1993)
particularly at the aa 68–80 region. The HA2 epitope
Note. ND, not done. (peptide 68-84) was found to be more effective than thea Splenic effector cells were obtained as described in Fig. 1.
other HA2 peptide (56-68) at both stimulator and targetb Effector cell to target cell ratio.
cell levels (Torres et al., 1988).
To define the specificity of CTL directed to the H3HA2,
we scanned the HA2 protein sequence for minimal class2k) or EL-4 (H-2b) targets sensitized with either influenza A
I consensus motifs described by others (Kulkarni et al.,virus or peptide 93-102 (Fig. 4). These results indicate
that influenza A virus immune BALB/c CTLs generated
with H3HA2 peptide 93-102 stimulation are H-2d re-
stricted and specific for the H3HA2-derived peptides. On
the basis of the Kd-specific binding motif contained within
these peptides, the CTL response seems to be H-2Kd
restricted.
DISCUSSION
With many viruses, complete protective immunity usu-
ally includes induction of an effective CD8/ CTL re-
sponse (Doherty et al., 1992; Schimd and Rouse, 1992).
Such responses occur if properly processed and assem-
bled antigens are presented to T lymphocytes by the
appropriate antigen presenting cells in the context of
class I MHC molecules (Brodsky and Guagliardi, 1991;
Knight and Stagg, 1993; Steinman, 1991; Bhardwaj et al.,
1994; Rouse et al., 1994). The CTL response to whole
influenza A virus is predominantely directed to internal
viral proteins, with NP-specific, type A cross-reactive CTL
being the major component of the polyclonal response
(Yewdell et al., 1985). However, HA-specific CTL re-
sponses can be detected in virus immune splenocytes
by infecting targets with recombinant vaccinia express-
ing the entire hemagglutinin (HA) including both the HA1
FIG. 2. H3HA2-VACC primes BALB/c mice for secondary in vitroand HA2 subunits. Studies with recombinant vaccinia
influenza A virus HA2-specific CD8/ CTL response: The recombinantviruses expressing the influenza H1 or H2 HA genes
vaccinia virus (H3HA2-VACC; 51 107 PFU) was used for in vivo immuni-showed that these CTL responses were largely subtype
zation; dendritic cells treated with peptide 93-102 were used for sec-
specific (Bennink et al., 1984, 1987; Townsend, 1987). ondary in vitro stimulation as described under Materials and Methods.
Later, studies with HA-specific CTL clones demonstrated Cytotoxic assays were performed with P815 (H-2d) targets after sensiti-
zation with recombinant vaccinia virus (H3HA2-VACC), influenza A virussome cross-reactivity between the H1 and H2 subtypes,
(A/PR/8/34, A/Udorn/72), and H3HA2-derived peptide 93-102 at effectorleading to the identification of a well-conserved H-2Kd-
cell to target cell ratios of 100:1 and 50:1. For peptide-sensitized targetsrestricted CTL epitope in the HA2 transmembrane region
the cytotoxicity assay was performed in the presence of an anti-CD8
(189-199) (Kuwano et al., 1989). Initial attempts to identify (53-6.72) or anti-CD4 (GK 1.5) monoclonal antibody at 10 mg/ml (final
CTL specific for the H3 subtype HA were unsuccessful concentration). Comparable results were obtained in independent ex-
periments.(Yewdell and Hackett, 1989). However, Itamura et al.
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fected with influenza A virus H1 (A/PR/8/34), H2 (A/JAP/
305/57), and H3 (A/Udorn/72) subtypes. Thus, our present
studies have shown that the cross-reactivity among all
three subtypes of influenza A virus reported by others
for NP now also exists for HA2 at the level of specific
CTL. This is most likely due to the high sequence homol-
ogy among H1, H2, and H3 subtypes in the HA2 se-
quence at amino acid residues corresponding to the 93-
102 epitope (Table 1). This was also further evident when
recombinant vaccinia virus (H3HA2-VACC) containing
the isolated H3HA2 gene was used for priming BALB/c
mice and in vitro stimulated with H3HA2 peptide 93-102
generated CTLs which recognized targets sensitized
with peptide 93-102, H3HA2-VACC, A/PR/8/34, A/JAP/57,
and A/Udorn/72 (Figs. 2 and 4). This suggests that the
epitope 93-102 is a cross-reactive epitope located in the
hemagglutinin HA2 of influenza virus type A.
This is the first definitive evidence that the H3HA2 can
act not only as a target antigen for influenza virus-specific
CTLs but can also prime in vivo and restimulate in vitro.
That is, the antigens are well expressed quantitatively
FIG. 3. MHC restriction of H3HA2-specific CTL from A/Udorn/72-
primed mice: BALB/c mice were immunized with A/Udorn/72 and ef-
fector cells were generated (as described in Fig. 1). P815 (H-2d) or EL-
4 (H-2b) targets were sensitized with the peptides shown or were in-
fected with A/Udorn/72 or A/PR/8/34, respectively. The E:T ratio was
50:1.
1993; Lipford et al., 1990; Pamer et al., 1991; Rotzchke
et al., 1991). Two potential epitopes based on the Kd
binding motif (Falk et al., 1991b) were identified (93-102
and 181-189). Epitope 93-102 was of the most interest
since this region is almost completely conserved be-
tween the H1, H2, and H3 subtypes. Furthermore, these
sequences (93-102) and (181-189) are also conserved in
most H3 influenza strains (Ward, 1981; Yuferov et al.,
1984). Since the HA-specific responses do not comprise
a major component of the polyclonal CTL response to
influenza virus, an enriched population of dendritic cells
pulsed with the H3HA2 peptide was used to preferen-
tially expand these CTL in vitro. In addition, recombinant
H3HA2 vaccinia were made and used to prime mice to
enrich for CTLs with this specificity without competition
from the other influenza proteins. We also confirmed that
CTL epitopes could be presented by target cells produc-
ing an intact HA2 protein.
The results showed that after in vitro stimulation of
virus immune splenocytes with the peptide H3HA2 93-
102 in bulk culture, P815 target cells sensitized with the
H3HA2-derived peptides (93-102) and (181-189) were
killed in a dose-dependent manner (Figs. 1A and 1B).
The specificity and MHC restriction of these CTLs were
clear, as reflected by the killing of H3HA2 peptide pulsed
FIG. 4. MHC restriction of H3HA2-specific CTL from H3HA2-VACC-syngeneic (H-2d) but not allogeneic (H-2b) cells, and by
primed mice: Immune spleen cells from H3HA2-VACC-primed mice
the failure of the CTL to recognize syngeneic cells sensi- were stimulated in vitro with dendritic cells either treated with peptide
tized with a Db-restricted epitope peptide (Fig. 3). The H3HA2 93-102 (solid bars) or infected with H3HA2-VACC (hatched
bars). P815 (H-2d), BW5147 (H-2k), or EL-4 (H-2b) were treated as shown.CTLs specific for H3HA2 epitopes recognize targets in-
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tive, H3HA2-specific CTLs are a component of the natural Cossins, J., Gould, K. G., Smith, M., Driscoll, P., and Brownlee, G. G.
immune response to an influenza infection. The CTL de- (1993). Precise prediction of a Kk-restricted cytotoxic T cell epitope
in the NS1 protein of influenza virus using an MHC allele specificterminants in H3 virus strains, as well as those ex-
motif. Virology 193, 289–295.pressed by H1 and H2 strains, were mapped to con-
Davis, M. M., and Bjorkman, P. J. (1988). T cell antigen receptor genesserved sequences representing the known Kd CTL motifs.
and T cell recognition. Nature 334, 395–402.
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